Before initiating a first-in-human clinical trial involving…
Before initiating a first-in-human clinical trial involving an unapproved drug, the sponsor is required to submit an application to the FDA for an Investigational New Drug (IND) exemption. This exemption authorizes the use of the unapproved drug in the trial without the need for a prescription.
Read Details